Kratom Industry Spends Millions Lobbying for Natural Products, Against Synthetics

The kratom industry has allocated millions of dollars towards political action committees, candidate campaigns, and lobbying initiatives. These efforts aim to prevent broad bans on kratom products and instead steer lawmakers toward regulating synthetic alternatives more stringently, according to available records.

The American Kratom Association has been a significant spender, reportedly investing over $1 million in lobbyists over the past decade, with $443,000 dedicated to such efforts in the current year. Among its key lobbyists are Mac Haddow, a veteran Capitol Hill figure and former Reagan administration official, and David Carlucci, a former New York State Senator.

Botanic Tonics, a supplement company founded by Jerry W. Ross, is reported to have led a multi-million dollar lobbying campaign. This campaign reportedly included private meetings with federal officials to advocate for the benefits of natural kratom, a substance derived from the leaves of a tropical tree native to Southeast Asia. The company also contributed $1.1 million to PACs associated with Robert F. Kennedy, a former presidential candidate and Health Secretary, and an additional $443,000 to the Republican National Committee. These contributions were reportedly intended to facilitate a private meeting between Ross and Vice President JD Vance to discuss potential crackdowns on high-potency 7-hydroxymitragynine (7-OH) and other synthetic kratom alternatives, while simultaneously safeguarding natural kratom supplements.

Allies of Ross also established a company named "Stop Gas Station Heroin," which promoted natural kratom as a safer alternative. This entity reportedly paid Checkmate Government Relations, a lobbying firm owned by Kennedy ally Ches McDowell, at least $750,000.

State Assemblyman Phil Steck acknowledged that the lobbying efforts spearheaded by the American Kratom Association, focusing on curbing synthetic kratom while promoting natural products, had been "effective" in New York. Steck, who sponsored legislation to ban synthetic kratom statewide, saw the bill approved by the Legislature in June, but it awaits Governor Kathy Hochul's signature into law.

Steck expressed that he would prefer a broader ban that includes natural kratom products, citing "dangerous side effects," though he conceded they were not as severe as those linked to synthetic versions. However, legislative leaders and the Governor's office have reportedly shied away from such an extensive approach.

Mac Haddow, also a senior fellow on public policy at the American Kratom Association, stated that the financial investments in lobbying and campaign contributions are essential for "getting a seat at the table" to ensure fair consideration by decision-makers, noting that the synthetic kratom industry engages in similar practices. He asserted that natural kratom offers significant health benefits, with its 24 million consumers in the U.S. primarily using it for energy enhancement, managing anxiety and depression, pain relief, and overcoming opioid addiction.

The U.S. Department of Justice recently announced steps to intensify regulatory actions against synthetic kratom, following recommendations from the U.S. Department of Health and Human Services. While HHS representatives declined to comment on the kratom industry's lobbying activities, Secretary Robert F. Kennedy Jr. issued a statement emphasizing a clear distinction between natural kratom and "dangerous, enhanced opioid products."